Putnam Investments’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $13.6M | Buy |
+124,187
| New | +$12.8M | 0.02% | 283 |
|
|
2022
Q3 | – | Sell |
-124,339
| Closed | -$11.9M | – | 1158 |
|
|
2022
Q2 | $11.9M | Sell |
124,339
-8,152
| -6% | -$978K | 0.02% | 274 |
|
|
2022
Q1 | $19.7M | Buy |
132,491
+5,096
| +4% | +$712K | 0.03% | 225 |
|
|
2021
Q4 | $18.1M | Buy |
127,395
+3,315
| +3% | +$470K | 0.03% | 269 |
|
|
2021
Q3 | $16.2M | Sell |
124,080
-270
| -0.2% | -$35.3K | 0.03% | 279 |
|
|
2021
Q2 | $17.1M | Hold |
124,350
| – | – | 0.03% | 279 |
|
|
2021
Q1 | $16.2M | Buy |
124,350
+10,178
| +9% | +$1.22M | 0.03% | 286 |
|
|
2020
Q4 | $12.8M | Buy |
114,172
+29,830
| +35% | +$2.82M | 0.02% | 328 |
|
|
2020
Q3 | $6.63M | Buy |
84,342
+3,361
| +4% | +$274K | 0.01% | 420 |
|
|
2020
Q2 | $5.83M | Buy |
80,981
+894
| +1% | +$62.2K | 0.01% | 440 |
|
|
2020
Q1 | $4.59M | Sell |
80,087
-285
| -0.4% | -$26.3K | 0.01% | 454 |
|
|
2019
Q4 | $8.99M | Sell |
80,372
-8,684
| -10% | -$925K | 0.02% | 388 |
|
|
2019
Q3 | $8.56M | Buy |
89,056
+3,377
| +4% | +$317K | 0.02% | 395 |
|
|
2019
Q2 | $7.33M | Buy |
85,679
+520
| +0.6% | +$42.7K | 0.02% | 436 |
|
|
2019
Q1 | $7.08M | Buy |
85,159
+49
| +0.1% | +$3.56K | 0.02% | 415 |
|
|
2018
Q4 | $5.46M | Buy |
85,110
+1,167
| +1% | +$79.9K | 0.01% | 453 |
|
|
2018
Q3 | $6.65M | Buy |
83,943
+63,246
| +306% | +$4.89M | 0.01% | 483 |
|
|
2018
Q2 | $1.51M | Buy |
+20,697
| New | +$1.41M | ﹤0.01% | 780 |
|
|
2017
Q2 | – | Sell |
-12,034
| Closed | -$534K | – | 1142 |
|
|
2017
Q1 | $534K | Sell |
12,034
-14,419
| -55% | -$620K | ﹤0.01% | 1098 |
|
|
2016
Q4 | $1.17M | Sell |
26,453
-229
| -0.9% | -$9.73K | ﹤0.01% | 972 |
|
|
2016
Q3 | $1.07M | Sell |
26,682
-30,631
| -53% | -$1.3M | ﹤0.01% | 1004 |
|
|
2016
Q2 | $2.73M | Buy |
57,313
+12,388
| +28% | +$524K | 0.01% | 836 |
|
|
2016
Q1 | $1.88M | Buy |
44,925
+881
| +2% | +$34.6K | ﹤0.01% | 964 |
|
|
2015
Q4 | $1.94M | Sell |
44,044
-410
| -0.9% | -$17.8K | ﹤0.01% | 982 |
|
|
2015
Q3 | $2.12M | Buy |
44,454
+1,403
| +3% | +$77K | ﹤0.01% | 978 |
|
|
2015
Q2 | $2.51M | Sell |
43,051
-45
| -0.1% | -$2.43K | 0.01% | 985 |
|
|
2015
Q1 | $2.18M | Sell |
43,096
-1,373
| -3% | -$67.3K | ﹤0.01% | 1030 |
|
|
2014
Q4 | $2M | Sell |
44,469
-43,935
| -50% | -$1.84M | ﹤0.01% | 1025 |
|
|
2014
Q3 | $3.26M | Buy |
88,404
+1,192
| +1% | +$47.3K | 0.01% | 904 |
|
|
2014
Q2 | $3.85M | Buy |
87,212
+169
| +0.2% | +$7.66K | 0.01% | 865 |
|
|
2014
Q1 | $3.78M | Sell |
87,043
-5,596
| -6% | -$249K | 0.01% | 866 |
|
|
2013
Q4 | $3.94M | Sell |
92,639
-1,362
| -1% | -$51.8K | 0.01% | 848 |
|
|
2013
Q3 | $3.19M | Sell |
94,001
-9,698
| -9% | -$316K | 0.01% | 909 |
|
|
2013
Q2 | $3.24M | Buy |
+103,699
| New | +$3.36M | 0.01% | 880 |
|
Other funds holding CNMD
CIP
Putnam Investments's CNMD Position: Q4 2023 in Review
Putnam Investments opened a new position in CONMED (CNMD) in Q4 2023: 124,187 shares worth $13.6M. The stake represents 0.02% of the portfolio and ranks #283 among its holdings. This is a return to the name: Putnam Investments previously reported a position in CNMD as recently as Q2 2022.
Putnam Investments first reported a position in CNMD in Q2 2013 and has held it in 34 quarters since. The position peaked at $19.7M in Q1 2022. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.
- Putnam Investments held 124,187 shares of CONMED worth $13.6M as of Q4 2023.
- CONMED was a new Putnam Investments position in Q4 2023.
- CONMED made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #283 holding.
- Putnam Investments first reported a position in CONMED in Q2 2013 and has held it in 34 quarters since.
- Putnam Investments's CONMED position peaked at $19.7M in Q1 2022.
- 306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.